The commercialization of bioinformatics

Electronic Journal of Biotechnology

Volumn 3, Issue 2, 2000, Pages 96-113

  Jones, Phillip B C ^a  

^a ZYMOGENETICS INC   (United States)

Author keywords

Computational biology; Nucleotide sequences; Pharmaceuticals

Indexed keywords

BIOINFORMATICS; BIOLOGY; BIOTECHNOLOGICAL PROCEDURES; COMPUTER; DATA BASE; DNA SEQUENCE; DRUG INDUSTRY; DRUG RESPONSE; DRUG TARGETING; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN GENOME; INTERNET; MEDICAL GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE ANALYSIS;

EID: 3242692428     PISSN: 07173458     EISSN: None     Source Type: Journal    
DOI: 10.2225/vol3-issue2-fulltext-4     Document Type: Review

References (128)

1. About the consortium. (1998). [Online]. Available: http://www. gatconsortium.org.
2. Appel, R. D. (1997). Interfacing and Integrating Databases. In: Proteome Research: New Frontiers in Functional Genomics, N. R. Wilkins (ed.), pp. 149-175. Springer-Verlag, Berlin.
3. Baldi, P. and Brunak, S. (1998). Bioinformatics - the machine learning approach. Cambridge, MA, The MIT Press.
4. Bellavance, L. L., Donlan, M.E. and Sharp, S. (1999). A bioinformatics primer. Genetic Engineering News 19:32-33.
5. Benton, D. (1996). Bioinformatics - principles and potential of a new multidisciplinary tool. TIBTECH 14:261-272.
6. Berners-Lee, T. (1999). Weaving the web., HarperCollins Publishers Inc., New York, USA, 226 pp.
7. Bioinformatics emerges as a key technology for developing new drugs. (1999). Chemical Market Reporter 255:22.
8. BioWorld® Publishing Group. (1999). BioWorld® 1999 genomics review: Companies leading the revolution., BioWorld® Publishing Group, Atlanta, GA, USA 110 pp.
9. Blanton, K. (1999, October 15). Gene pool. The Boston Globe H01.
10. Boguski, M. S. (1999). Biosequence exegesis. Science 286:453-455.
11. Brocklehurst, S. M., Hardman, C. M. and Johnston, S. J. T. (1999). Creating integrated computer systems for target discovery and drug discovery. In: Pharmainformatics: A Trends Guide, M. Owen (ed.), pp. 12-15. Elsevier Science Ltd., New York.
12. Butler, D. (1999). "Finishing" success marks major genome sequencing milestone . . . Nature 402:447-448.
13. Cantor, C. R. and Smith, C. L. (1999). Genomics: The science and technology behind the Human Genome Project. John Wiley and Sons, Inc., New York, USA, 596 pp.
14. Celera Genomics completes sequencing phase of the genome from one human being. (2000). [Online]. Available: http://www.pecorporation.com.
15. Company says it filed 10,000 gene patents. (2000). [Online]. Available: http://dailynews.yahoo.com.
16. Cook, J. L. (1999). Internet biomolecular resources. Analytical Biochemistry 268:165-172.
17. Cook-Deegan, R. (1994). The Gene Wars. W. W. Norton and Company, Inc., New York, USA, 416 pp.
18. Corporate backgrounder. (2000). [Online]. Available: http://www.incyte. com.
19. Corporate profile. (1999). [Online]. Available: http://www.hgsi.com/ cprofile/index.html.
20. Crooke, S. T. (1998). Optimizing the impact of genomics on drug discovery and development. Nature Biotechnology 16:29-30.
21. Czarnik, A. W. (1998). Illuminating the SNP genomic code. Modern Drug Discovery 1:49-55.
22. Data mining. (1999). Start-up 4:7-13.
23. Data security. (2000). [Online]. Available: http://www.labonweb.com.
24. Department of Energy (DOE) Human Genome Program. (1992). Primer on Molecular Genetics. Oakridge TN, Human Genome Management Information System.
25. Dickson, D. and Macilwain, C. (1999). "It's a G": The one-billionth nucleotide. Nature 402:331.
26. Discala, C., Ninnin, M., Achard, F., Barillot, E. and Vaysseix, G. (1999). DBcat: A catalog of biological databases. Nucleic Acids Research 27:10-11.
27. Drews, J. (1999). Informatics: Coming to grips with complexity. In: Pharmainformatics: A Trends Guide, M. Owen (ed.), pp.1-2. Elsevier Science Ltd. New York.
28. DoubleTwist Security Statement. (2000). [Online]. Available: http://www.doubletwist.com.
29. Drowning in data. (1999). The Economist 351:93-94.
30. Durso, T. W. (1997). As genomics grows, future for bioinformatics is bright. The Scientist 11:13.
31. Eisner, R. (1991). Second wave of biotechnology revolution to crest with a new generation of drugs. The Scientist 5:1,8-9.
32. Enough to go around. (1996). The Scientist 10:30.
33. Evans, W. E. and Relling, M. V. (1999). Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 286:487-491.
34. Fickel, L. (2000). Writing the book of life. CIO Magazine. [Online]. Available: http://www2.cio.com/ Corresponding author e-mail: RiceKid@ix.netcom.com
35. Fields, C. (1996). Informatics for ubiquitous sequencing. Trends in Biotechnology 14:286-289.
36. Fisher, L. M. (1999, August 26). The race to cash in on the genetic code. [Online]. Available: http://www.nytimes.com.
37. Fisher, L. M. (1994). Profits and ethics clash in research on genetic coding. [Online]. Available: http://www.nytimes.com.
38. Frew, J. (1998). Biotechnology's metamorphosis into a drug discovery industry. Nature Biotechnology 16:22-24.
39. Frishman, D., Heumann, K., Lesk, A. and Mewes, H.W. (1998). Comprehensive, comprehensible, distributed and intelligent databases: Current status. Bioinformatics 14:551-561.
40. Gaasterland, T. (1998). Structural genomics: Bioinformatics in the driver's seat. Nature Biotechnology 16:625-627.
41. Gardner, S. (1999). The evolution of bioinformatics. BITS Journal. [Online]. Available: http://www.bitsjournal.com. Corresponding author e-mail: stevegardner@csi.com.
42. Gardner, S. P. and Flores, T. P. (1999). Integrating information technology with pharmaceutical discovery and development. In: Pharmainformatics: A Trends Guide. M. Owen (ed.), pp.2-5. Elsevier Science Ltd., New York.
43. Genome Canada: Planning session. (1999). [Online]. Available: http://www.genomecanada.ca.
44. George, D. (1999). Bioinformatics outsourcing: The gains of letting go. Drug Discovery Online. [Online]. Available: http://www.drugdiscoveryonline.com.
45. Gershon, D. (1997). Bioinformatics in a post-genomics age. Nature 389:417-418.
46. Gershon, D. (1995). The boom in bioinformatics. Nature 375:262.
47. Gillis, J. (1999, October 26). Md. gene researcher draws fire on filings. The Washington Post, E01.
48. Hamilton, J. O'C. (1992, March 2). Biotech: America's dream machine. Business Week 3254:66-69, 73-74.
49. Harris, G. (2000, February 9). How Merck plans to cope with patent expirations. The Wall Street Journal, Eastern Edition A1.
50. Henig, P. D. (1999). Rent-A-Gene.com. Red Herring 73:156-168.
51. HGS touts July 2001 Independence Day: All collaborations will expire. (1999). The Pink Sheet 61:24.
52. Hieter, P. and Boguski, M. (1997). Functional Genomics: It's all how you read it. Science 278:601-602.
53. Hoke, F. (1994). Limited access to cDNA database has drug manufacturer up in arms. The Scientist 8:1.
54. Hoyle, B. (1999). Giga-speed bioinformatics to power Genome Canada. Nature Biotechnology 17:950.
55. Hui, L. (2000). Money and machines fuel China's push in sequencing. Science 288:795-798.
56. Human Genome Sciences, Inc. (1999). [Online]. Available: http://www.hoovers.com
57. Jain, K. K. (1999). Strategies and technologies in functional genomics. Drug Discovery Today 4:50-53.
58. Japan aims to launch 1,000 biotech companies in 10 years. (1999). Nature 397:554.
59. Johnson, D. (1999). The discovery-development interface has become the new interfacial phenomenon. Drug Discovery Today 4:535-536.
60. Jones, S. B. and Franklin, J. (1998). A strategy and demonstration for integrated biotechnology information. Disease Markers 13:237-243.
61. Jordan, B. R. (1999). "Genomics": Buzzword or reality? Journal of Biomedical Science 6:145-150.
62. Klevecz, R. (1999). The whole EST catalog. The Scientist 13:22-23.
63. Kruglyak, L. (1999). Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nature Genetics 22:139-144.
64. Ladd, B. (2000). Intuitive data analysis: The next generation. Modern Drug Discovery 3:46-52.
65. Larvol, B. L. and Wilkerson, L. J. (1998). In silico drug discovery: Tools for bridging the NCE gap. Nature Biotechnology 16:33-34.
66. Lewis, R. (2000). Clinton, Blair stoke debate on gene data. The Scientist 14:1,18,21.
67. Lewis, R. (1996). Software helps researchers in sorting through the human genome. The Scientist 10:18-19.
68. Licking, E., Barret, A., Rae-Dupree, J., Carey, J. and Capell, K. (2000). Move over, dot-coms. Biotech is back. Business Week 3671:116-122.
69. Loder, N. (1999). Genetic variations can point the way to disease genes. Nature 401:734.
70. Longman, R. (1999). Racing biotech's commoditization clock. In Vivo 17:46-53.
71. Madden, A. P. (1998). I am pharma, hear me roar. Red Herring Online. [Online]. Available: http://www.redherring.com. Corresponding author e-mail: edit@herring.com
72. Manufacturing. (2000). [Online]. Available: http://www.hgsi.com.
73. Marshall E. and Pennisi, E. (1998). Hubris and the human genome. Science 280:994-995.
74. Marshall, E. (1997). Genomic's odd couple. Science 275:778-780.
75. Murray-Rust, P. (1994). Bioinformatics and drug discovery. Current Opinion in Biotechnology 5:648-653.
76. National Human Genome Research Institute. (1999). [Online]. Available: http://www.nhgri.nih.gov.
77. National Human Genome Research Institute. (1998). Reading the sequence of human DNA. [Online]. Available: http://www.nhgri.nih.gov:80/NEWS.
78. Noguchi, T. (1996). Turning towards applied research in genetic information: Helix Research Institute begins research. Kazusa Special Edition. [Online]. Available: http://www.pref.vhiba.jp/Business/Kazusa/Hotline/Vol.16/s pecial-e.html.
79. O'Brien, S. (2000). DNA adds drama to biotech industry. CBS MarketWatch. [Online]. Available: http://app.marketwatch.com.
80. O'Neill, M. D. (1999). BioLIMS™ Information management system is crucial to target ID at Chugai Biopharmaceuticals. BioBeatSM. [Online]. Available: http://www.biobeat.com. Corresponding author e-mail: oneillmd@pebio.com.
81. Osborne, R. (2000). Researchers decode 3 more chromosomes: 5, 16 and 19. BioWorld®Today 11:1-2.
82. Oscar Gruss issues bioinformatics report. (2000). [Online]. Available: http://www.prnewswire.com.
83. Patents. (2000). [Online]. Available: http://www.hgsi.com.
84. Pennisi, E. (1999). Seeking common language in a tower of Babel. Science 286:449.
85. Pennisi, E. (1998). DNA sequencers' trial by fire. Science 280:814-817.
86. Perkin-Elmer, Dr. J. Craig Venter, and TIGR announce formation of new genomics company. (1998). [Online]. Available: http://www.pe-corp.com/press/ prc5447.html
87. Persidis, A. (2000). Data mining in biotechnology. Nature Biotechnology 18:237.
88. Persidis, A. (1999). Bioinformatics. Nature Biotechnology 17:828-830.
89. Pickering, L. (1999a). Bioinformatics comes of age. Genetic Engineering News 19:10, 30, 40.
90. Pickering, L., (1999b). Gene expression analysis. Genetic Engineering News 19:1, 18, 54, 64.
91. Pickering, L. (1999c). Fully integrating bioinformatics. Genetic Engineering News 19:21, 42, 52-54, 56.
92. Pickering, L. (1998). Anatomy of a bioinformatics deal. Genetic Engineering News 18:12, 37, 44, 48.
93. Pipeline: Functional Genomics. (2000). [Online]. Available: http://www.hgsi.com/pipeline/index.html.
94. Purcell, D. J. (1998). Navigating biotechnology's new fiscal opportunities. Nature Biotechnology 16:51-53.
95. Rastan, S. and Beeley, L. J. (1997). Functional genomics: Going forwards from the databases. Current Opinion in Genetics and Development 7:777-783.
96. Ratner, M. (1999). Should platform companies move toward products? Nature Biotechnology 17:16-17.
97. Regalado, A. (2000). G-Commerce. [Online]. Available: http://www.techreview.com Corresponding author: regalado@mit.edu.
98. Regalado, A. (1999). Mining the Genome. Technology Review. [Online]. Available: http://www.techreview.com/articles/oct99/regalado.htm. Corresponding author e-mail: regalado@mit.edu.
99. Roberts, L. (2000). SNP mappers confront reality and find it daunting. Science 287:1898-1899.
100. Roberts, L. (1999, October 18). A short cut to the gene pool. [Online]. Available: http://www.usnews.com/usnews/home.htm
101. Rosenberg, R. (2000, February 18). On Wall Street, a buzz over biotech. Boston Globe C01.
102. Russo, E. and Smaglik, P. (1999). Big Pharma hedges its bets. The Scientist 13:1,8,32.
103. Saegusa, A. (1999a). Japan pushes to capitalize on biotechnology. Nature Biotechnology 17:320-321.
104. Saegusa, A. (1999b). Japan declares five-year plan to double genome research funds. Nature 400:389.
105. Saegusa, A. (1999c). Japan joins effort to patent cDNA clones. Nature 401:520.
106. Sainsbury, D. (1999). Biotechnology clusters. London, Department of Trade and Industry.
107. Šali, A. (1999). Functional links between proteins. Nature 402:23-26.
108. Schachter, B. (1998). Pharming the genome. H.M.S. Beagle. Issue 41. [Online]. Available: http://www.biomednet.com/hmsbeagle. Corresponding author e-mail: drbethie@walrus.com.
109. Slater, G. St. C. (1998). Human EST sequences. In: Guide to Human Genome Computing, M. J. Bishop (ed.), pp. 205-214. Academic Press, San Diego, CA.
110. Smaglik, P. (1998). Private genome sequencing effort may hasten separate public venture. The Scientist 12:1-5.
111. Smith, C. (1999). Computational gold. The Scientist 13:21-23.
112. Smith, T. F. (1990). The history of the genetic sequence databases. Genomics 6:701-707.
113. Sobral, B. W. S. (1997). Common language of bioinformatics. Nature 389:418.
114. Strausberg, R. L. and Austin, M. J. F. (1999). Functional genomics: Technological challenges and opportunities. Physiological Genomics 1:25-32.
115. Technology. (1999). [Online]. Available: http://www.curagen.com.
116. The history of Incyte. (2000). [Online]. Available: http://www.incyte. com.
117. The SNP timeline. (1999). The Scientist 13:9.
118. Touchman, J. W. and Green, E. D. (1998). The genomic revolution: Enabling technologies of the Human Genome Project. Focus 20:58-61.
119. Triendl, R. (2000). Genomic forges ahead in East Asia. Nature Biotechnology 18:278-279.
120. Van Brunt, J. (1999). Restless in Seattle. Signals. [Online]. Available: http://www.signalsmag.com. Corresponding author e-mail: signals_edit@recap.com
121. Venter, J. C., Adams, M.D., Sutton, G.G., Kerlavage, A.R., Smith, H.O. and Hunkapiller, M. (1998). Shotgun sequencing of the human genome. Science 280:1540-1542.
122. Wade, N. (1999, October 26). Rivals reach milestones in genome race. [Online]. Available: http://www.nytimes.com.
123. Wade, N. (1998, August 18). New company joins race to sequence human genome. [Online]. Available: http://www.nytimes.com.
124. Wadman, M. (2000). Balance is returning after US biotechnology shares scare. Nature 404:424.
125. Waldholtz, M., Tanouye, E. and Harris, G. (1999 November 4). With executives aging and patents expiring, industry is ripe for megamergers. The Wall Street Journal B1, B4.
126. Wedin, R. (1999). Visual data mining speeds drug discovery. Modern Drug Discovery 2:39-47.
127. Wickelgren, I. (1999). Mining the genome for drugs. Science 285:998-1001.
128. Wilde, O. (1994). An ideal husband. In: The Complete Works of Oscar Wilde. New York, Barnes and Noble Books. pp. 482-551